ID

10572

Descrizione

S0023 LUNG CARCINOMA FOLLOW UP FORM NCT00020709 S0023: Combination Chemo Plus RT With or Without Gefitinib in Treating Patients With Unresectable Stage III NSCLC Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9CB6D1D2-A964-34E4-E034-080020C9C0E0

collegamento

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9CB6D1D2-A964-34E4-E034-080020C9C0E0

Keywords

versioni (3)
  1. 19/09/12 19/09/12 -
  2. 28/05/15 28/05/15 -
  3. 03/06/15 03/06/15 -
Caricato su

3 giugno 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0 Legacy
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

S0023 LUNG CARCINOMA FOLLOW UP FORM NCT00020709

Inglese

No Instruction available.

1 moduli  
  1. StudyEvent: S0023 LUNG CARCINOMA FOLLOW UP FORM
    1. No Instruction available.
SWOG clinical trial administrative data
Descrizione

SWOG clinical trial administrative data

SWOG Patient ID
Descrizione

SWOGPatientID

Tipo di dati

text

SWOG Study No.
Descrizione

SWOGStudyNo.

Tipo di dati

text

Registration Step
Descrizione

RegistrationStep

Tipo di dati

text

Alias
NCI Thesaurus ValueDomain
C25337
UMLS 2011AA ValueDomain
C0237753
NCI Thesaurus ValueDomain
C16154
UMLS 2011AA ValueDomain
C1704379
Patient Initials (L, F,M)
Descrizione

PatientInitials

Tipo di dati

text

Institution / Affiliate
Descrizione

Institution/Affiliate

Tipo di dati

text

Physician
Descrizione

Physician

Tipo di dati

text

Group Name (Groups other than SWOG )
Descrizione

GroupName

Tipo di dati

text

Study No. (Groups other than SWOG )
Descrizione

StudyNo.

Tipo di dati

double

Pt. ID (Groups other than SWOG )
Descrizione

Pt.ID

Tipo di dati

text

Vital Status
Descrizione

Vital Status

Vital Status
Descrizione

VitalStatus:

Tipo di dati

text

Date of last contact or death (If vital status is Dead, complete and submit Notice of Death form.)
Descrizione

Dateoflastcontactordeath:

Tipo di dati

text

Disease Follow Up Status
Descrizione

Disease Follow Up Status

Has the patient had a documented clinical assessment for this cancer since submission of the previous follow-up form?
Descrizione

Hasthepatienthadadocumentedclinicalassessmentforthiscancersincesubmissionofthepreviousfollow-upform?

Tipo di dati

text

If Yes, Date of Last Clinical Assessment
Descrizione

IfYes,DateofLastClinicalAssessment:

Tipo di dati

text

Has the patient developed a first relapse or progression that has not been previously reported?
Descrizione

Hasthepatientdevelopedafirstrelapseorprogressionthathasnotbeenpreviouslyreported?

Tipo di dati

text

If Yes, Date of Relapse or Progression
Descrizione

IfYes,DateofRelapseorProgression:

Tipo di dati

text

If yes, please submit the Lung Carcinoma First Site(s) of Progression or Relapse Form.
Descrizione

Ifyes,pleasesubmittheLungCarcinomaFirstSite(s)ofProgressionorRelapseForm.

Tipo di dati

text

Notice Of New Primary
Descrizione

Notice Of New Primary

Has a new primary cancer or myelodysplastic syndrome (MDS) been diagnosed that has not been previously reported?
Descrizione

Hasanewprimarycancerormyelodysplasticsyndrome(MDS)beendiagnosedthathasnotbeenpreviouslyreported?

Tipo di dati

text

If Yes, Date of Diagnosis
Descrizione

IfYes,DateofDiagnosis:

Tipo di dati

text

New Primary Site
Descrizione

NewPrimarySite:

Tipo di dati

text

Non-protocol Treatment
Descrizione

Non-protocol Treatment

Has the patient received any non-protocol cancer therapy (prior to progression/relapse) not previously reported?
Descrizione

Hasthepatientreceivedanynon-protocolcancertherapy(priortoprogression/relapse)notpreviouslyreported?

Tipo di dati

text

If Yes, Date of First Non-Protocol Therapy
Descrizione

IfYes,DateofFirstNon-ProtocolTherapy:

Tipo di dati

text

Agents
Descrizione

Agents:

Tipo di dati

text

Long Term Toxicity
Descrizione

Long Term Toxicity

Has the patient experienced (prior to treatment for progression or relapse or a second primary, and prior to non-protocol treatment) any severe (grade =>3) long term toxicity that has not been previously reported?
Descrizione

Hasthepatientexperienced(priortotreatmentforprogressionorrelapseorasecondprimary,andpriortonon-protocoltreatment)anysevere(grade=>3)longtermtoxicitythathasnotbeenpreviouslyreported?

Tipo di dati

text

If Yes, Toxicities and Grades
Descrizione

IfYes,ToxicitiesandGrades:

Tipo di dati

text

Notes
Descrizione

Notes

Notes
Descrizione

Notes

Tipo di dati

text

Ritorna all'inizio della pagina

Similar models

No Instruction available.

1 moduli
  1. StudyEvent: S0023 LUNG CARCINOMA FOLLOW UP FORM
    1. No Instruction available.
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
SWOG clinical trial administrative data
SWOGPatientID
Item
SWOG Patient ID
text
SWOGStudyNo.
Item
SWOG Study No.
text
RegistrationStep
Item
Registration Step
text
C25337 (NCI Thesaurus ValueDomain)
C0237753 (UMLS 2011AA ValueDomain)
C16154 (NCI Thesaurus ValueDomain)
C1704379 (UMLS 2011AA ValueDomain)
PatientInitials
Item
Patient Initials (L, F,M)
text
Institution/Affiliate
Item
Institution / Affiliate
text
Physician
Item
Physician
text
GroupName
Item
Group Name (Groups other than SWOG )
text
StudyNo.
Item
Study No. (Groups other than SWOG )
double
Pt.ID
Item
Pt. ID (Groups other than SWOG )
text
Item Group
Vital Status
Item
Vital Status
text
CL.1
Code List
Vital Status
CL Item
Alive (Alive)
CL Item
Dead (Dead)
Dateoflastcontactordeath:
Item
Date of last contact or death (If vital status is Dead, complete and submit Notice of Death form.)
text
Item Group
Disease Follow Up Status
Item
Has the patient had a documented clinical assessment for this cancer since submission of the previous follow-up form?
text
CL.2
Code List
Has the patient had a documented clinical assessment for this cancer since submission of the previous follow-up form?
CL Item
No (No)
CL Item
Yes (Yes)
IfYes,DateofLastClinicalAssessment:
Item
If Yes, Date of Last Clinical Assessment
text
Item
Has the patient developed a first relapse or progression that has not been previously reported?
text
CL.3
Code List
Has the patient developed a first relapse or progression that has not been previously reported?
CL Item
No2007229 (No)
CL Item
Yes2007230 (Yes)
IfYes,DateofRelapseorProgression:
Item
If Yes, Date of Relapse or Progression
text
Ifyes,pleasesubmittheLungCarcinomaFirstSite(s)ofProgressionorRelapseForm.
Item
If yes, please submit the Lung Carcinoma First Site(s) of Progression or Relapse Form.
text
Item Group
Notice Of New Primary
Item
Has a new primary cancer or myelodysplastic syndrome (MDS) been diagnosed that has not been previously reported?
text
CL.4
Code List
Has a new primary cancer or myelodysplastic syndrome (MDS) been diagnosed that has not been previously reported?
CL Item
No2007235 (No)
CL Item
Yes2007236 (Yes)
IfYes,DateofDiagnosis:
Item
If Yes, Date of Diagnosis
text
NewPrimarySite:
Item
New Primary Site
text
Item Group
Non-protocol Treatment
Item
Has the patient received any non-protocol cancer therapy (prior to progression/relapse) not previously reported?
text
CL.5
Code List
Has the patient received any non-protocol cancer therapy (prior to progression/relapse) not previously reported?
CL Item
No2007241 (No)
CL Item
Yes2007242 (Yes)
IfYes,DateofFirstNon-ProtocolTherapy:
Item
If Yes, Date of First Non-Protocol Therapy
text
Agents:
Item
Agents
text
Item Group
Long Term Toxicity
Item
Has the patient experienced (prior to treatment for progression or relapse or a second primary, and prior to non-protocol treatment) any severe (grade =>3) long term toxicity that has not been previously reported?
text
CL.6
Code List
Has the patient experienced (prior to treatment for progression or relapse or a second primary, and prior to non-protocol treatment) any severe (grade =>3) long term toxicity that has not been previously reported?
CL Item
No2007247 (No)
CL Item
Yes2007248 (Yes)
IfYes,ToxicitiesandGrades:
Item
If Yes, Toxicities and Grades
text
Item Group
Notes
Notes
Item
Notes
text
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial